Ronald Blue Trust, Inc. Hutchmed (China) LTD Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 4,168 shares of HCM stock, worth $68,605. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,168
Previous 7,068
41.03%
Holding current value
$68,605
Previous $101,000
40.59%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HCM
# of Institutions
70Shares Held
6.77MCall Options Held
8.2KPut Options Held
9.2K-
Schroder Investment Management Group London, X02.77MShares$45.6 Million0.04% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.12MShares$18.5 Million0.02% of portfolio
-
Ubs Group Ag378KShares$6.22 Million0.0% of portfolio
-
State Street Corp Boston, MA348KShares$5.72 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$5.19 Million0.12% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.85B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...